OMUFA Reauthorization: US FDA Would Identify Rx-OTC Switch Candidates, Work With Sponsors

The bill provisions support a bipartisan interest in promoting more Rx to OTC switches. (Shutterstock)

More from Post-Marketing Regulation & Studies

More from United States